A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

February 10, 2026

Study Completion Date

September 30, 2026

Conditions
Primary Immunodeficiency Diseases (PID)
Interventions
BIOLOGICAL

TAK-881

Participants will receive SC infusion of TAK-881.

BIOLOGICAL

HYQVIA

Participants will receive SC infusion of HYQVIA.

Trial Locations (32)

5000

Odense University Hospital, Odense

8200

Aarhus Universitetshospital, Aarhus

10461

Montefiore Medical Center, The Bronx

11021

Northwell Health, Great Neck

14300

Fakultni Nemocnice v Motole, Prague

27705

Duke Asthma, Allergy and Airway Center, Durham

28046

University Hospital La Paz, Madrid

31201

Central Georgia Infectious Disease Consultants, Macon

33701

University of South Florida, St. Petersburg

43235

Optimed Research, LTD, Columbus

61761

Sneeze, Wheeze, & Itch Associates, LLC, Normal

62500

University Hospital Brno (Fakultni Nemocnice Brno) - Children's Hospital (Detska nemocnice), Brno

70118

Louisiana State University Health Science Center-New Orleans, New Orleans

72076

Universitaetsklinikum Tuebingen (UKT), Tübingen

74136

Vital Prospects Clinical Research Institute, PC, Tulsa

75230

Allergy Partners of North Texas, Dallas

80206

National Jewish Medical And Research Center, Denver

84107

Tanner Clinic, Murray

90329

Osrodek Pediatryczny im. DR J. Korczaka, Wojewodzkie Wielospecjalistyczne Centrum i Traumatologii im. M. Kopernika w Lodzi, Lodz

92697

University of California Irvine Medical Center, Irvine

94598

Allergy and Asthma Clinical Research, Walnut Creek

60612-3852

Rush University Medical Center - University Cardiovascular Surgeons, Chicago

656 91

Fakultni nemocnice u sv. Anny v Brne - ICRC, Brno

01307

University Hospital Carl Gustav Carus, Dresden

3584 CX

Universitair Medisch Centrum Utrecht (UMC Utrecht), Utrecht

00-999

Instytut Pomnik - Centrum Zdrowia Dziecka, Warsaw

04-141

Wojskowy Instytut Medyczny,Centralny Szpital Kliniczny Ministerstwa Obronty Narodowej, Warsaw

80-952

Uniwersyteckie Centrum Kliniczne, KLINIKA PEDIATRII, HEMATOLOGII I ONKOLOGII, Gdansk

833 40

NUDCH (National Institute of Children's Diseases), Bratislava

040 01

OKIA, s.r.o, Košice

036 01

Klinika Deti a Dorastu - Odborne Ambulancie UNM a JLF UK Martin, Martin

08950

Hospital Sant Joan de Deu Barcelona, Esplugues de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Takeda Development Center Americas, Inc.

INDUSTRY

lead

Takeda

INDUSTRY

NCT05755035 - A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases | Biotech Hunter | Biotech Hunter